|
02 Mar 2007 |
Acambis’ JE vaccine meets and exceeds primary endpoint in pivotal Phase 3 efficacy trial
|
|
01 Mar 2007 |
Phase I Data From Targeted Genetics' tgAAC09 Vaccine for HIV/AIDS Presented at Scientific Conference
|
|
27 Feb 2007 |
Merck KGaA: Stimuvax Cancer Vaccine Phase III Study Begins
|
|
24 Feb 2007 |
Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval
|
|
24 Feb 2007 |
Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
|
|
23 Feb 2007 |
Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
|
|
22 Feb 2007 |
Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
|
|
20 Feb 2007 |
New Data Support Alphavax's Vaccine For CMV
|
|
16 Feb 2007 |
The Immune Response Corporation's Interim Phase II Data Suggest Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV Patients
|
|
15 Feb 2007 |
Acambis signs JE partnership agreement with sanofi pasteur
|
|
15 Feb 2007 |
Study Published in The New England Journal of Medicine: 55 Percent Fewer Cases of Flu in Young Children Vaccinated With FluMist(R) Vs. Flu Shot
|
|
14 Feb 2007 |
Transgene Initiates A Phase I Trial of its Therapeutic Vaccine Candidate TG4040 for Patients Chronically Infected With the Hepatitis C Virus
|
|
14 Feb 2007 |
First Patients Undergo Surgery in Northwest Biotherapeutics' Phase II Brain Cancer Trial
|
|
13 Feb 2007 |
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
|
|
13 Feb 2007 |
Favrille Announces Long-Term Follow-Up Data From Phase 2 Clinical Trial of FavId Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin's Lymphoma
|
|
10 Feb 2007 |
Personalized Immunotherapy Clinical Trial Initiated in HIV Patients with Argos Therapeutics' AGS-004
|
|
09 Feb 2007 |
Africa's First Large-Scale HIV Vaccine Study Launches
|
|
06 Feb 2007 |
Human Trial Results Show Excellent Safety Data, Positive Immune Responses From GeoVax's DNA/MVA AIDS Vaccines
|
|
02 Feb 2007 |
Generex Biotechnology to Initiate Phase II Clinical Trials in Breast Cancer Patients in Collaboration with United States Military's Cancer Institute
|
|
01 Feb 2007 |
B-Cell Chronic Lymphocytic Leukemia Clinical Trial Initiated with Argos Therapeutics’ AGS-005 Personalized Immunotherapy
|
|
30 Jan 2007 |
GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
|
|
30 Jan 2007 |
Introgen's INGN 225 Molecular Cancer Vaccine Demonstrates Promising Results in Phase 2 Trial
|
|
30 Jan 2007 |
Alphavax Announces Clinical Trials For Influenza And Cmv
|
|
27 Jan 2007 |
Placebo-controlled phase IIa study with hypertension vaccine CYT006-AngQb shows reduction in day-time blood pressure
|
|
27 Jan 2007 |
Crucell's PER.C6(R)-based West Nile Vaccine Demonstrates Excellent Safety and Tolerability
|
